Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Endothelial oncogenic KRAS mutation drives the dynamics of microglia and macrophages in brain arteriovenous malformation
Hyejin Park, Jung-Eun Park, Bridger H. Freeman, Bosco Seong Kyu Yang, Shun-Ming Ting, Alexander K. Suh, Jude P.J. Savarraj, Shuning Huang, Jakob Körbelin, Huimahn Alex Choi, Sean P. Marrelli, Jaroslaw Aronowski, Peng Roc Chen, Eunhee Kim, Eun S. Park
Hyejin Park, Jung-Eun Park, Bridger H. Freeman, Bosco Seong Kyu Yang, Shun-Ming Ting, Alexander K. Suh, Jude P.J. Savarraj, Shuning Huang, Jakob Körbelin, Huimahn Alex Choi, Sean P. Marrelli, Jaroslaw Aronowski, Peng Roc Chen, Eunhee Kim, Eun S. Park
View: Text | PDF
Research Article Neuroscience Vascular biology

Endothelial oncogenic KRAS mutation drives the dynamics of microglia and macrophages in brain arteriovenous malformation

  • Text
  • PDF
Abstract

Mutation of KRAS in endothelial cells (KRAS-ECs) leads to intracerebral hemorrhage (ICH) in brain arteriovenous malformation (bAVM), resulting in severe disabilities or even death. However, it is unclear what causes this hemorrhagic conversion of bAVMs. Here, using a locally established, clinically relevant sporadic bAVM mouse model, created by overexpressing mutant KRAS (KRASG12V) in brain ECs, we demonstrate that KRAS-ECs act as trigger for activation of microglia (MG) and infiltration of macrophages (Mϕ). Using a 3-dimensional immunostaining approach with cleared human and mouse bAVM tissues, we demonstrate an abundance of MG/Mϕ around the bAVM nidus. The presence of MG/Mϕ was correlated to the blood-brain barrier leakage in bAVM areas. Time-lapsed intravital imaging in Cx3cr1-gfp;Ccr2-rfp reporter mice demonstrated the dynamic activation of MG and infiltration of Mϕ toward mutant KRASG12V–modified dysplastic vessels. Importantly, a time-course analysis showed that these activated MG and infiltrated Mϕ are present around the bAVMs prior to hemorrhagic conversion, and controlled depletion of MG/Mϕ reduced ICH incidence in bAVMs. Inhibition of MG/Mϕ with long-term minocycline treatment attenuated the incidence of ICHs around bAVMs. Our study indicates that MG/Mϕ are involved in destabilization of KRASG12V-induced bAVM, leading to hemorrhagic conversion/ICH. Thus, modulation of MG/Mϕ may reduce ICH risk in patients with bAVM.

Authors

Hyejin Park, Jung-Eun Park, Bridger H. Freeman, Bosco Seong Kyu Yang, Shun-Ming Ting, Alexander K. Suh, Jude P.J. Savarraj, Shuning Huang, Jakob Körbelin, Huimahn Alex Choi, Sean P. Marrelli, Jaroslaw Aronowski, Peng Roc Chen, Eunhee Kim, Eun S. Park

×

Figure 2

Human bAVMs display the presence of MG/Mϕ in bAVM territories.

Options: View larger image (or click on image) Download as PowerPoint
Human bAVMs display the presence of MG/Mϕ in bAVM territories.
(A) A rup...
(A) A ruptured bAVM nidus dissected from a human patient was cleared using the tissue rapid clearing technique. bAVM nidus thickness: 2 mm. Representative immunofluorescence image of endothelium (CD31, green) and MG/Mϕ (Iba1, red) at the location (red inset of A) in cleared ruptured bAVM nidus. Scale bars: 200 μm (top) and 50 μm (bottom). (B) Representative immunofluorescence image demonstrating Iba1+ cells and CCR2+ cells in human ruptured and unruptured bAVM tissues compared to non–bAVM-associated superficial temporal artery (STA) used as control. Note that the dissected STA and bAVM are composed primarily of blood vessels and lack parenchymal tissue. Scale bar: 50 μm. (C) Bar graphs quantifying numbers of CCR2+ and Iba1+ cells between human STA, ruptured, and unruptured bAVM tissues. One-way ANOVA and Tukey’s multiple comparisons test. **P < 0.01; ****P < 0.0001. Each dot indicates a randomly selected ROI (n = 16–17) obtained from human images (n = 3) per group. (D) External validation: Reanalysis of bulk RNA-seq by comparing ruptured (n = 26 donors) versus unruptured human bAVM tissues (n = 13 donors), and scRNA-seq by comparing Ctrl (control adult vessels from epilepsy patients, n = 5 donors) versus unruptured human bAVM tissues (n = 5 donors), based on the dataset by Winkler et al. (30). Created in BioRender (https://BioRender.com/w59711f). (E) External validation: MG and Mϕ in the bulk RNA-seq dataset express their respective markers: TMEM119 and P2RY12 (MG) and LY86 (Mϕ). Note that the MG/Mϕ genes are significantly expressed in the ruptured bAVM tissues compared with the unruptured bAVM tissues. Proportions of selected genes for MG and Mϕ were compared between ruptured and unruptured using nonparametric statistical tests (log2[fold change]). (F–I) External validation: UMAP visualization of immune cell types from reanalyzed scRNA-seq data of Ctrl and unruptured bAVM tissues (F). Mϕ, macrophages; DC, dendritic cell; MY, myeloid; MO, monocytes; MG, microglia; DI, dividing immune cells; BC, B cell; TC, T cell; NK, natural killer cells. No significant batch effect was observed. Note that the proportions of MG and Mϕ are similar compared to control vessels (G), while the unruptured bAVM tissues have increased CD68 and AIF1 in MG (H and I). All analyses were conducted in R version 4.3. Fisher’s exact tests were used to determine the statistical significance of cell proportions. The significance of selected genes was tested with Wilcoxon’s rank-sum tests to compare Ctrl and unruptured. P = 0.00718 (AIF1), P = 0.0241 (CD68).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts